We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

181 hedge funds and large institutions have $1.73B invested in Nektar Therapeutics in 2015 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 53 increasing their positions, 45 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 23

38% more call options, than puts

Call options by funds: $6.54M | Put options by funds: $4.74M

24% more capital invested

Capital invested by funds: $1.39B → $1.73B (+$338M)

18% more funds holding

Funds holding: 153 → 181 (+28)

18% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 45

Holders
181
Holders Change
+28
Holders Change %
+18.3%
% of All Funds
4.87%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
51
Increased
53
Reduced
45
Closed
23
Calls
$6.54M
Puts
$4.74M
Net Calls
+$1.8M
Net Calls Change
-$2.58M

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$50.7M
2
First Trust Advisors
First Trust Advisors
Illinois
+$39.3M
3
CCM
Camber Capital Management
Massachusetts
+$17.2M
4
GAM
Gotham Asset Management
New York
+$15.6M
5
BA
BlackRock Advisors
Delaware
+$14.1M

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$41.1M
2
BIT
BlackRock Institutional Trust
California
-$13.2M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$11.4M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$7.72M
5
DFO
Duquesne Family Office
New York
-$7.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
51
Perceptive Advisors
New York
$4.19M +$3.84M +22,333 New
OA
52
OFI Advisors
Pennsylvania
$4.02M +$3.68M +21,412 New
William Blair & Company
53
William Blair & Company
Illinois
$3.99M +$342K +1,988 +10%
Deutsche Bank
54
Deutsche Bank
Germany
$3.69M -$1.66M -9,639 -33%
Prudential Financial
55
Prudential Financial
New Jersey
$3.67M +$3.24M +18,820 +2,483%
TA
56
Teachers Advisors
New York
$3.59M +$96.7K +562 +3%
USAA
57
United Services Automobile Association
Texas
$3.54M – – –
Jacobs Levy Equity Management
58
Jacobs Levy Equity Management
New Jersey
$3.49M +$1.97M +11,466 +161%
TC
59
TFS Capital
Pennsylvania
$3.33M +$3.05M +17,731 New
Comerica Bank
60
Comerica Bank
Texas
$3.32M +$3.05M +17,702 New
HHC
61
Hutchin Hill Capital
New York
$3.24M +$2.97M +17,267 New
California State Teachers Retirement System (CalSTRS)
62
California State Teachers Retirement System (CalSTRS)
California
$3M +$87.9K +511 +3%
California Public Employees Retirement System
63
California Public Employees Retirement System
California
$2.95M -$136K -788 -5%
Asset Management One
64
Asset Management One
Japan
$2.83M -$92.2K -536 -3%
Allianz Asset Management
65
Allianz Asset Management
Germany
$2.58M -$6.49M -37,729 -73%
BAMS
66
Bellevue Asset Management (Switzerland)
Switzerland
$2.5M +$964K +5,600 +72%
Public Sector Pension Investment Board (PSP Investments)
67
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.5M +$2.29M +13,333 New
TAM
68
Tocqueville Asset Management
New York
$2.34M -$110K -640 -5%
New York State Common Retirement Fund
69
New York State Common Retirement Fund
New York
$2.3M +$1.55M +9,015 +277%
BG
70
BlackRock Group
United Kingdom
$2.29M +$1.32M +7,642 +168%
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
$2.06M -$30.1K -175 -2%
TL
72
Tirschwell & Loewy
New York
$1.93M -$6.18M -35,883 -78%
Swiss National Bank
73
Swiss National Bank
Switzerland
$1.83M +$59.5K +346 +4%
Bank of America
74
Bank of America
North Carolina
$1.8M +$1.57M +9,114 +1,868%
MC
75
Menta Capital
California
$1.8M +$1.65M +9,587 New
1 2
3
4 5

NKTR Hedge Fund Activity: Q2 2015 in Review

181 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q2 2015, worth a combined $1.73B — up 24% from $1.39B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new NKTR positions and 23 closed out — a net gain of 28 holders — while 53 added to existing stakes and 45 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $50.7M. The largest seller was JP Morgan Chase, cutting an estimated $41.1M.

  • 181 institutional investors held Nektar Therapeutics (NKTR) as of Q2 2015, up from 153 in Q1 2015.
  • Funds reported $1.73B of Nektar Therapeutics stock for Q2 2015, up 24% quarter-over-quarter.
  • 51 funds opened new Nektar Therapeutics positions in Q2 2015 and 23 closed out, a net change of +28 holders.
  • The largest Nektar Therapeutics buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $50.7M added.
  • The largest Nektar Therapeutics seller in Q2 2015 was JP Morgan Chase, an estimated $41.1M sold.

Based on aggregated 13F filings for Q2 2015.